ALEF.V - Aleafia Health Inc.

TSXV - TSXV Delayed Price. Currency in CAD
2.2600
0.0000 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.2600
Open2.3100
Bid2.2800 x 0
Ask2.2800 x 0
Day's Range2.2400 - 2.3100
52 Week Range2.2400 - 2.3100
Volume1,555,593
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateNov 26, 2018 - Nov 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • The 5 Worst-Performing Pot Stocks in April
    Motley Fool

    The 5 Worst-Performing Pot Stocks in April

    Two of the most popular marijuana stocks face-planted last month.

  • GlobeNewswire

    Aleafia Health to add 50,000 kg Extraction Capacity at Paris, ON Facility

    Company Expecting to Complete Phase II Expansion in Q3 2019 TORONTO, April 16, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the.

  • GlobeNewswire

    Aleafia Health Applauds Commitment to Private Retail Expansion in Ontario Budget

    Company has Equity Stakes and Supply Agreements With Three Major Retail PartnersBudget Announced Major Expansion of Cannabis Retail Licences in Canada’s Largest Province.

  • GlobeNewswire

    Aleafia Health Opens the Market

    TORONTO, April 11, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) opened the market at the Toronto Stock Exchange (“TSX”) in.

  • Aleafia Health Increases Strategic Investment in Australian LP CannaPacific
    GlobeNewswire

    Aleafia Health Increases Strategic Investment in Australian LP CannaPacific

    CannaPacific Also Closes its Acquisition of 108,000 sq. ft. Greenhouse for Cannabis CultivationAustralian LP is Federally Licensed to Cultivate and Research Cannabis TORONTO.

  • Aleafia Health to Announce 2018 Financial Results
    GlobeNewswire

    Aleafia Health to Announce 2018 Financial Results

    TORONTO, April 09, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) will announce its 2018 Financial Results on April 29, 2019.

  • Aleafia Health Launches Cannabis Education Platform FoliEdge Academy
    GlobeNewswire

    Aleafia Health Launches Cannabis Education Platform FoliEdge Academy

    FoliEdge Academy Built with D2L, a World Leading Online Learning CompanyInsurance Technology Executive Rob Tyrie Named Head of FoliEdge AcademyInteractive, Cloud-based Courses.

  • These Worst-Performing Pot Stocks Fell at Least 20% in March
    Motley Fool

    These Worst-Performing Pot Stocks Fell at Least 20% in March

    There are some very familiar marijuana stocks among this bunch of losers.

  • GlobeNewswire

    Aleafia Health Appoints Lead Independent Director

    TORONTO, April 04, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has appointed Loreto Grimaldi as the Lead Independent.

  • ACCESSWIRE

    CVS and Walgreens Are Betting Big on the Future of Cannabis Demand

    HOUSTON, TX / ACCESSWIRE / April 3, 2019 / Cannabis has already disrupted alcohol, cigarettes, food, pharmaceuticals, and the global wellness industry. Even major retailers are jumping on board, seeing ...

  • Aleafia Health Commences Trading on the Toronto Stock Exchange
    GlobeNewswire

    Aleafia Health Commences Trading on the Toronto Stock Exchange

    TORONTO, March 19, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to confirm that the Company’s common shares.

  • Baystreet

    Retailers are Just Beginning to Bring CBD to Mass Retail Consumers

    The CBD retail boom is upon us. As cannabis-infused products find their way into major retailers, ...

  • CNW Group

    Newly Expanding Sectors Cause an Updraft to the Overall Cannabis Market

    NEW YORK, March 19, 2019 /CNW/ -- The cannabis plant is undergoing rapid proliferation around the world. Most of these countries are legalizing cannabis for medical use, but some are possibly looking to legalize it for recreational use as well. Recreationally, cannabis is becoming a new source of economic growth, primarily within the U.S. and Canada.

  • Aleafia Health Funded Study Finds Increase in Employment Among Epileptic Medical Cannabis Patients
    GlobeNewswire

    Aleafia Health Funded Study Finds Increase in Employment Among Epileptic Medical Cannabis Patients

    Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), announced the results of a 4,000 medical cannabis patient study (“The Study”) examining changes in employment and disability status among medical cannabis patients. The study was published on March 13, 2019 in the peer-reviewed Journal of Drug Issues, and is, to the Company and author’s knowledge, the first to ever directly observe physician-led medical cannabis usage and labour force status over time.

  • CNW Group

    Cannabis Reaches New Demographics Due to its Medical Appeal

    The statistics show that cannabis consumption has increased among the older generations since the previous survey in 2013 as almost a quarter of those over 65 were prescribed cannabis as a treatment from their doctors in 2016. While recreational cannabis laws are still regulated in most U.S. states and even internationally, medical cannabis regulations are much more lenient because of the plant's therapeutic effects. Now, consumers are using cannabis to treat medical conditions such as cancer, chronic pain, and arthritis.

  • Aleafia Health and Emblem Announce Closing of Arrangement
    GlobeNewswire

    Aleafia Health and Emblem Announce Closing of Arrangement

    TORONTO, March 14, 2019 -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health”) and Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem”) are pleased to.

  • Aleafia Health to Graduate to Toronto Stock Exchange
    GlobeNewswire

    Aleafia Health to Graduate to Toronto Stock Exchange

    Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announced today that the Company has received conditional approval from the Toronto Stock Exchange (“TSX”) to graduate from the Toronto Venture Exchange (“TSXV”) and list its common shares on the TSX under the symbol “ALEF”. Listing on the TSX is subject to TSX final approval which is conditional upon the completion of the Company’s previously announced acquisition of Emblem Corp. (TSXV: EMC, OTCQX: EMMBF).  In conjunction with listing on the TSX, the common shares will be voluntarily delisted from the TSXV prior to the commencement of trading on the TSX.

  • CNW Group

    New Products Shake up the Burgeoning Cannabis Industry

    NEW YORK, March 4, 2019 /CNW/ -- The development of the cannabis industry has led to the introduction of a variety of products into the marketplace in recent years. Predominantly, consumers are using these products for medical applications to treat conditions like cancer, migraine, and arthritis. Such as it is, the current emergence of wide-ranging products is diversifying and helping grow the overall cannabis industry.

  • Baystreet

    How the 2019 Academy Awards Rolled out the Carpet for CBD Stocks

    CBD made headlines at the 2019 Academy Awards. In fact, actress Melissa McCarthy reportedly applied ...

  • Aleafia Becomes First Cannabis Stock to Top TSX Venture 50 Performance Rankings -- CFN Media
    GlobeNewswire

    Aleafia Becomes First Cannabis Stock to Top TSX Venture 50 Performance Rankings -- CFN Media

    SEATTLE, Feb. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Aleafia Health Inc. (ALEF.V) (ALEAF) (ARAH.F). The vertically-integrated licensed producer with a clinic network and over 50,000 patients, was named as the 2019 TSX Venture 50 top performing company of the year. The TSX Venture exchange has become a popular place for cannabis companies to list their shares, particularly after Canada legalized recreational cannabis last year, but 2019 was the first year that a cannabis company topped its annual performance rankings.

  • GlobeNewswire

    Clarification Regarding Press Release Issued by Unrelated Third Party

    Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), is providing an update regarding a press release (the “Press Release”) issued by an unrelated third party. A Press Release issued by Aura Health Inc. (“Aura”) entitled “With a Strategic Investment by Aleafia Health, Aura Health Announces Increase to Previously Announced Brokered Subscription Receipt Financing to $7.26 Million” came to the attention of the Company. Although the Company was solicited to participate in Aura’s private placement, Aleafia Health is not negotiating a subscription agreement, nor has the Company had the opportunity to perform due diligence or submit the participation to the TSX Venture Exchange for acceptance.

  • VIDEO: Aleafia Health Named Top Performing Company of the Year for TSX Venture 50
    GlobeNewswire

    VIDEO: Aleafia Health Named Top Performing Company of the Year for TSX Venture 50

    Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has been named the TMX Group’s 2019 TSX Venture 50 top performing company of the year amongst all 2,000 TSX Venture Exchange listed companies. The award was based on three equally weighted criteria, market capitalization growth, share price appreciation and trading volume.

  • CNW Group

    Demand for Legal Cannabis Continues to Rise Around the World

    NEW YORK, Feb. 21, 2019 /CNW/ -- As the cannabis market continues its rapid development, cultivators and suppliers alike are tasked with meeting the demands of various consumers. Some of these countries are seeking suppliers for medical cannabis to treat cumbersome conditions such as cancer, mental disorders, and chronic pain. As legalization continues to spread around the globe, the demand will gradually increase, thus accelerating the overall cannabis industry growth.

  • Aleafia Health Announces new President of Clinic Operations
    GlobeNewswire

    Aleafia Health Announces new President of Clinic Operations

    White to Lead Integration of Canabo Medical Clinics and GrowWise Health Post-closing of Emblem AcquisitionPreviously the COO of Canada’s Largest Multidisciplinary Clinic Network.

  • GlobeNewswire

    Aleafia Health Helps Patients & Investors with Revenue Generating Research -- CFN Media

    SEATTLE, Wash., Feb. 07, 2019 (GLOBE NEWSWIRE) -- -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article featuring Aleafia Health Inc. (ALEF.V) (ALEAF) (ARAH.F). The company is well-equipped to study the effects of cannabis with its wholly-owned network of more than 20 Canabo Medical Clinics with over 50,000 patients. Aleafia Health’s research division generated $612,000 in revenue in Q3 2018, and the Company is building on that success.